Causes and Management of Aseptic Meningitis : A Retrospective Cohort Study in Strasbourg University Hospital (Meningitis)

December 8, 2023 updated by: University Hospital, Strasbourg, France
The diagnostic and therapeutic management of patients with aseptic meningitis is a challenge for the practitioner. There are many etiologies of this condition (infectious, inflammatory, neoplastic, drug-induced), which it is necessary to know how to evoke and look for specifically.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Strasbourg, France, 67091
        • Service de Médecine interne et d'Immunologie Clinique - CHU de Strasbourg - France

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Major subject (≥18 years old) with aseptic meningitis (CSF pleocytosis, negative bacteriology) from January 2015 to October 2020, at HUS

Description

Inclusion criteria:

  • Major subject (≥18 years old)
  • Subject with aseptic meningitis (CSF pleocytosis, negative bacteriology) from January 2015 to October 2020, at HUS
  • Subject having not expressed, after being informed, their opposition to the reuse of their data for the purposes of this research.

Exclusion criteria:

  • Subject who expressed their opposition to participating in the study
  • Subject under guardianship or curatorship
  • Subject under safeguard of justice
  • Positive VZV, HSV, or Enterovirus PCR in CSF
  • CSF analysis performed as part of the assessment of a known pathology
  • Traumatic or surgical etiology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Retrospective study of the etiologies of aseptic meningitis infection in Alsace
Time Frame: Files analysed retrospectively from January 01, 2015 to October 31, 2020 will be examined
Files analysed retrospectively from January 01, 2015 to October 31, 2020 will be examined

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2021

Primary Completion (Actual)

October 20, 2021

Study Completion (Actual)

December 20, 2021

Study Registration Dates

First Submitted

October 14, 2022

First Submitted That Met QC Criteria

October 18, 2022

First Posted (Actual)

October 19, 2022

Study Record Updates

Last Update Posted (Estimated)

December 11, 2023

Last Update Submitted That Met QC Criteria

December 8, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aseptic Meningitis

3
Subscribe